Patent directory · USPTO A61K / A61P
Patents matching “MEREO BIOPHARMA 1 LIMITED”
9 pharma patents match "MEREO BIOPHARMA 1 LIMITED" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 9 pharmaceutical patents matching "MEREO BIOPHARMA 1 LIMITED" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11701341
Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the treatment of acute exacerbations of chronic obstructive pulmonary disease
granted -
US 11434204
Method for producing a polymorphic form of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamide
granted -
US 11234967
Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention or reduction of acute exacerbations of chronic obstructive pulmonary disease
granted -
US 11129810
Dosage regimen for the treatment of acute exacerbations of chronic obstructive pulmonary disease
granted -
US 10995071
Method for producing a polymorphic form of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamide
granted -
US 10934260
Method for producing a polymorphic form of 3-[5-amino-4-(3- cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamide
granted -
US 10617674
Dosage regimen for the treatment of acute exacerbations of inflammatory conditions
granted -
US 10603306
Dosage regimen for the treatment of acute exacerbations of chronic obstructive pulmonary disease
granted -
US 9339491
Use of a pyrazole derivative in the treatment of acute exacerbations of chronic obstructive pulmonary disease
granted